Just in case you haven't heard the news, 'There have been “very exciting” developments over the last decade in the treatment of CLL, Dr Kanti Rai (of CLL Rai staging fame) told HemOnc Today': healio.com/hematology-oncol...
Neil
Ibrutinib, idelalisib, venetoclax provide ‘ver... - CLL Support
Ibrutinib, idelalisib, venetoclax provide ‘very exciting developments’ in CLL - Dr Kanti Rai
AussieNeilPartnerAdministrator
Written by
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
Vaccines, Ibrutinib toxicity,Dr. Rai on a cure, Dr Ghia on TP563 testing and ERIC
I warned that our website's pages would be busy through the end of the year.
I tried to synthesize...
Frontline Venetoclax/Obinutuzumab Approved in Europe for CLL
In some welcome good news, "The European Commission has approved a fixed-dose combination of...
Dr. Wierda on the paradigm shift in CLL.
Dr. Wierda is my doctor and in the short time I met with him in 2017, I didn’t get the impression...
Stopping ibrutinib and imaging in CLL
Hi,
I stopped ibrutinib after almost 8 years. I discuss my thoughts and emotions around saying...
Exciting times in CLL: an ASCO 2013 interview with Dr Susan O’Brien
I just came across this bit obscure video with Dr. Susan O'Brien of MD Anderson...you may find it...
Related Posts
- ASH 2018: Dr. Lindsey Roeker, on real world use of venetoclax for CLL (chronic lymphocytic leukemia)
Role of RITUXIMAB in CLL treatment in combination with Venetoclax- Dr. Mato on what really happens when we must stop our ibrutinib or idelalisib
CD3xCD19 Dart Treatment Is Efficient in Venetoclax Resistant CLL and Reverses T Cell Dysfunction - ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL
